Adnexal Mass Clinical Trial
Official title:
Subharmonic Contrast Ultrasound for Improved Characterization for Adnexal Masses-A Pilot Study
This pilot clinical trial studies how well contrast-enhanced subharmonic ultrasound imaging works in improving the characterization of adnexal masses in patients undergoing surgery. Contrast-enhanced subharmonic ultrasound imaging uses high-frequency sound waves to produce images of internal organs and when combined with an ultrasound agent such as perflutren lipid microspheres, may help improve imaging and management of adnexal masses.
PRIMARY OBJECTIVES: I. To develop qualitative subharmonic imaging (SHI) or SHI-derived quantitative biomarkers. II. To generate pilot data for a study to evaluate if they improve the characterization of benign and malignant adnexal masses compared to standard ultrasound or contrast enhanced magnetic resonance imaging (MRI) or the risk of malignancy index (RMI). SECONDARY OBJECTIVES: I. To compare the SHI depiction of adnexal masses' neovascularity in humans to intra-tumoral microvascular density (iMVD) obtained from CD31 an immunohistochemical marker of angiogenesis. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05815992 -
Accuracy of the Characterization of Adnexal Masses, Indeterminate at Ultrasonography, Using a MRI Protocol Without Contrast: Validation of the Cambridge Score
|
||
Completed |
NCT06366997 -
Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test
|
||
Completed |
NCT00987649 -
Ovarian Cancer Risk Estimation in Patients With Pelvic Mass
|
N/A | |
Completed |
NCT04260334 -
Preoperative Care In Ovarian Cancer Patients
|
N/A | |
Terminated |
NCT04668521 -
Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection
|
||
Recruiting |
NCT05842629 -
Improved Diagnosis of Ovarian Cancer
|
||
Recruiting |
NCT05974618 -
Prospective Validation of the ADNEX Model for Discrimination Between Benign and Malignant Adnexal Masses in Pregnancy: International Ovarian Tumour Analysis in Pregnancy Study (p-IOTA)
|
||
Terminated |
NCT04487405 -
A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants
|
||
Recruiting |
NCT05017246 -
Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy
|
Phase 2 | |
Not yet recruiting |
NCT05761275 -
Assessment of Women's Sexual Quality of Life After Benign Adnexal Surgery Using vNOTES Approach
|
N/A | |
Not yet recruiting |
NCT03442881 -
The Use of International Ovarian Tumor Analysis and Assessment of Adnexal Neoplasia in Differentiating Malignant and Benign Adnexal Masses
|
N/A | |
Completed |
NCT01466049 -
New Biomarkers Evaluating Ovarian Cancer
|
N/A | |
Terminated |
NCT03485651 -
Natera Ovarian Cancer Detection Assay
|
||
Active, not recruiting |
NCT04051502 -
ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
|
||
Recruiting |
NCT05051722 -
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
|
||
Completed |
NCT03593681 -
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
|
||
Completed |
NCT02520115 -
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
|
Phase 1 | |
Recruiting |
NCT05461872 -
Retrospective Review on PAEDIATRIC and ADOLESCENT ADNEXAL MASSES
|
||
Completed |
NCT03837327 -
Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy
|